The following is a summary of “Barriers and facilitators to sustaining a lupus patient decision aid in regular rheumatology ...

Biogen has bagged $250 million to advance a key pipeline prospect. | Biogen has bagged $250 million to advance a key pipeline ...

The agreement hands Biogen as much as $250 million in exchange for milestone payments and sales royalties for litifilimab, ...

The funding agreement comes as Biogen revealed a modest Q4 sales beat, which analysts expect will be “overshadowed” by the ...

Requiring erythema alone for entry into cutaneous lupus erythematosus trials may exclude patients with skin of color and increase health disparities, according to a study. Tacrolimus appears to ...

17."At eight years old, I got my period. Obviously concerned about how young I was, my mom took me to the doctor. The doctor ...

Selena Gomez has been in the spotlight thanks to her Golden Globe nomination for Emilia Pérez and her engagement to musician ...

More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may ...

Roche’s subsidiary Genentech has shared positive Phase III data with the US Food and Drug Administration (FDA) as the company targets the billion-dollar lupus market for its CD20-targeting drug Gazyva ...

Systemic lupus erythematosus (SLE ... In addition, magnetic resonance imaging has recently shown limbic system involvement in SLE patients. “Although the exact mechanism of olfactory impairment ...

In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive ...